Low back pain epidemiology and demographics

Jump to navigation Jump to search

Low back pain Microchapters

Home

Overview

Pathophysiology

Causes

Differentiating Low back pain from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Conservative Management

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Low back pain epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Low back pain epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Low back pain epidemiology and demographics

CDC on Low back pain epidemiology and demographics

Low back pain epidemiology and demographics in the news

Blogs on Low back pain epidemiology and demographics

Directions to Hospitals Treating Low back pain

Risk calculators and risk factors for Low back pain epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Keanu Ngo[2]

Overview

Low back pain (LBP) is the leading cause of years lived with disability (YLDs) worldwide. Prevalence is higher in women and rises with age, and age-standardized burden is highest in high-income settings. Case counts are rising with population growth and aging, although age-standardized rates declined slightly from 1990 to 2021.[1][2]

Global burden

  • GBD 2020 estimate: 619 million prevalent cases in 2020, projected to reach 843 million by 2050.[3][4]
  • GBD 2021 estimate: 629 million prevalent cases (95% UI 552–701 million), 267 million incident cases (95% UI 235–299 million), and 70.16 million DALYs (95% UI 65.76–83.22 million).[2] The 2020 and 2021 figures come from different GBD releases and should not be pooled.
  • Trend, 1990–2021: age-standardized prevalence (EAPC −0.32), incidence (EAPC −0.29), and DALY (EAPC −0.32) rates declined slightly, while absolute numbers rose substantially.[1][2]
  • Rank: LBP was a leading cause of YLDs in 2021.[1]

Prevalence

  • Lifetime prevalence in adults is approximately 40%.[3]
  • Point prevalence varies with case definition and source (roughly 12–18% in major reviews). Estimates of lifetime prevalence reach as high as 84% in some reports.[4]
  • Nonspecific LBP accounts for about 80–90% of cases. Radicular pain has a prevalence of 5–10%. See Low back pain classification.
  • GBD estimates use a case definition (pain between the 12th ribs and gluteal folds lasting at least a day) that differs from clinical definitions.

Age

  • The number of affected individuals peaks at ages 50–54 in both sexes, whereas prevalence rates peak at 80–84 years in GBD 2021.[1][2]
  • JAMA describes prevalence peaking around age 85, which reflects GBD 2020 age grouping.[3]
  • Pediatric and adolescent epidemiology is not covered here.

Sex

  • Women have higher prevalence at all ages in most GBD analyses, and the gap widens with age. Age-standardized prevalence in 2020 was 9330 versus 5520 per 100,000 in females versus males.[3][1]
  • Sex patterns vary by country. In the Iranian GBD 2019 analysis, males had higher rates in most age groups.[5]

Geography and socioeconomic status

  • Highest age-standardized burden is in high-SDI regions and Central Europe (Hungary). Asia and China have the largest case numbers. Middle-SDI regions had the lowest age-standardized rates.[2]
  • Age-standardized YLD rates correlated positively with the Socio-demographic Index globally.[1]
  • Greatest increases in age-standardized prevalence from 1990 to 2021 were in Tropical Latin America and Sweden.[1]
  • Within the United States, YLD rates correlate inversely with SDI across census divisions.[6]
  • Data from low- and middle-income countries are sparser than from Europe, North America, and Australia.

United States

  • GBD 2021: age-standardized prevalence 10,670 and YLD rate 1179 per 100,000, decreases of 7% and 8% versus 1990.[6]
  • Prevalence is higher in females at all ages. By region, the Midwest has the highest burden and the Northeast the lowest. By division, East South Central is highest and New England lowest. Burden increases with age and in more recent periods.[6]
  • Race and ethnicity: a systematic review of 23 studies found some incidence studies with higher risk of chronic LBP in Black than White adults, and data for Hispanic and Latino adults are limited. Prevalence studies showed higher rates in White and American Indian and Alaska Native adults and lower rates in Black, Hispanic and Latino, and Asian adults.[4]
  • Among primary care patients with acute LBP, high-impact chronic LBP at 6 months was more frequent in Black (30%) and Hispanic (25%) than White (15%) patients. Adjusted odds remained significant for Black patients (aOR 1.40, 95% CI 1.05–1.87) but not Hispanic patients.[7]
  • In US active-duty service members, acute LBP incidence was 37.74 per 1000 person-years, highest in Black and lowest in Asian/Pacific Islander personnel.[8]

Attributable and associated factors

  • Globally, occupational ergonomic factors, high BMI, and smoking are the leading attributable risk factors.[9] See Low back pain risk factors.
  • In the US, high BMI, smoking, and occupational ergonomic factors together accounted for 43% of LBP-related YLDs.[6]
  • Associations with obesity (OR 1.5), depressive symptoms (OR 1.6), and heavy lifting are detailed in the risk factor chapter.[3]

Limitations of the data

  • GBD estimates are model-based (DisMod-MR 2.1) with wide uncertainty intervals.[6]
  • Duration cutoffs differ across sources (acute <4 versus <6 weeks), affecting incidence and chronicity estimates.[4]
  • Subnational surveillance in the US is limited.[6]
  • Race and ethnicity data are heterogeneous, and no studies examined subacute LBP.[4]

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Cheng M, et al. Global, Regional, and National Burden of Low Back Pain: Findings From the Global Burden of Disease Study 2021 and Projections to 2050. Spine. 2025. PMID 39838749.
  2. ↑ 2.0 2.1 2.2 2.3 2.4 Fu J, et al. Epidemiological Trends and Geographic Disparities in Low Back Pain Burden Based on the 2021 GBD Study. Medicine. 2026. PMID 42299523.
  3. ↑ 3.0 3.1 3.2 3.3 3.4 Cashin AG, Chou R, Weimer MB, McAuley JH. Low Back Pain: A Review. JAMA. 2026.
  4. ↑ 4.0 4.1 4.2 4.3 4.4 Burke CA, et al. Racial and Ethnic Disparities in the Incidence and Prevalence of Low Back Pain in the United States: A Systematic Review. Arthritis Care & Research. 2026.
  5. ↑ Sanjari M, et al. National and subnational burden and attributable risk factors of osteoarthritis, rheumatoid arthritis, and low back pain in Iran: 1990–2019 findings of the Global Burden of Disease (GBD) Study. PLoS One. 2023.
  6. ↑ 6.0 6.1 6.2 6.3 6.4 6.5 Jung R, et al. The Burden of Low Back Pain in the United States, 1990 to 2021: An Observational Study Based on the Global Burden of Disease Study 2021. Medicine. 2026. PMID 42601699.
  7. ↑ Roseen EJ, et al. Racial and Ethnic Disparities in the Incidence of High-Impact Chronic Pain Among Primary Care Patients With Acute Low Back Pain. Pain Medicine. 2023. PMID 36534910.
  8. ↑ Knox JB, Orchowski JR, Owens B. Racial Differences in the Incidence of Acute Low Back Pain in United States Military Service Members. Spine. 2012. PMID 22460922.
  9. ↑ Li Y, et al. Global Burden of Low Back Pain and Its Attributable Risk Factors From 1990 to 2021. Frontiers in Public Health. 2024. PMID 39606072.

Template:WH Template:WS